Maftivimab monotherapy is effective in a non-human primate model of Bundibugyo virus disease
Meike Dittmann, Dylan M. Johnson, Micah Rapp, Alida Coppi, Flonza Isa, Dharani K. Ajithdoss, Anbo Zhou, Benjamin O. Fulton, Ranu Basu, Anna K. Kania, Kristen E. Pascal, Robert LeDesma, George Ehrlich, Ashique Rafique, Victoria Marzec, , Jamie Marie Orengo
This study shows Maftivimab neutralizes BDBV-2026 and protects non-human primates from BDBV disease when administered after infection.
bioRxiv · Oct 14, 2026 · PreprintImmunology